-
1
-
-
77953995002
-
Covalent histone modifications-miswritten, misinterpreted and mis-erased in human cancers
-
Chi P, Allis CD, Wang GG. Covalent histone modifications-miswritten, misinterpreted and mis-erased in human cancers. Nat Rev Cancer. 2010;10(7):457-469.
-
(2010)
Nat Rev Cancer
, vol.10
, Issue.7
, pp. 457-469
-
-
Chi, P.1
Allis, C.D.2
Wang, G.G.3
-
2
-
-
84860371953
-
Epigenetic protein families: A new frontier for drug discovery
-
Arrowsmith CH, Bountra C, Fish PV, Lee K, Schapira M. Epigenetic protein families: a new frontier for drug discovery. Nat Rev Drug Discov. 2012;11(5):384-400.
-
(2012)
Nat Rev Drug Discov
, vol.11
, Issue.5
, pp. 384-400
-
-
Arrowsmith, C.H.1
Bountra, C.2
Fish, P.V.3
Lee, K.4
Schapira, M.5
-
3
-
-
34548526743
-
Chromatin remodeling and cancer Part I: Covalent histone modifications
-
Wang GG, Allis CD, Chi P. Chromatin remodeling and cancer, Part I: Covalent histone modifications. Trends Mol Med. 2007;13(9): 363-372.
-
(2007)
Trends Mol Med
, vol.13
, Issue.9
, pp. 363-372
-
-
Wang, G.G.1
Allis, C.D.2
Chi, P.3
-
4
-
-
75749124332
-
Somatic mutations altering EZH2 (Tyr641) in follicular and diffuse large B-cell lymphomas of germinal-center origin
-
Morin RD, Johnson NA, Severson TM, et al. Somatic mutations altering EZH2 (Tyr641) in follicular and diffuse large B-cell lymphomas of germinal-center origin. Nat Genet. 2010;42(2): 181-185.
-
(2010)
Nat Genet
, vol.42
, Issue.2
, pp. 181-185
-
-
Morin, R.D.1
Johnson, N.A.2
Severson, T.M.3
-
5
-
-
80052029516
-
Frequent mutation of histone-modifying genes in non-Hodgkin lymphoma
-
Morin RD, Mendez-Lago M, Mungall AJ, et al. Frequent mutation of histone-modifying genes in non-Hodgkin lymphoma. Nature. 2011; 476(7360):298-303.
-
(2011)
Nature
, vol.476
, Issue.7360
, pp. 298-303
-
-
Morin, R.D.1
Mendez-Lago, M.2
Mungall, A.J.3
-
6
-
-
84895815322
-
Integrated genomic analysis identifies recurrent mutations and evolution patterns driving the initiation and progression of follicular lymphoma
-
Okosun J, Bödör C, Wang J, et al. Integrated genomic analysis identifies recurrent mutations and evolution patterns driving the initiation and progression of follicular lymphoma. Nat Genet. 2014;46(2):176-181.
-
(2014)
Nat Genet
, vol.46
, Issue.2
, pp. 176-181
-
-
Okosun, J.1
Bödör, C.2
Wang, J.3
-
7
-
-
78751662908
-
The Polycomb complex PRC2 and its mark in life
-
Margueron R, Reinberg D. The Polycomb complex PRC2 and its mark in life. Nature. 2011; 469(7330):343-349.
-
(2011)
Nature
, vol.469
, Issue.7330
, pp. 343-349
-
-
Margueron, R.1
Reinberg, D.2
-
8
-
-
84885393469
-
Transcriptional regulation by Polycomb group proteins
-
Di Croce L, Helin K. Transcriptional regulation by Polycomb group proteins. Nat Struct Mol Biol. 2013;20(10):1147-1155.
-
(2013)
Nat Struct Mol Biol
, vol.20
, Issue.10
, pp. 1147-1155
-
-
Di Croce, L.1
Helin, K.2
-
9
-
-
84873417354
-
An H3K36 methylation-engaging Tudor motif of polycomblike proteins mediates PRC2 complex targeting
-
Cai L, Rothbart SB, Lu R, et al. An H3K36 methylation-engaging Tudor motif of polycomblike proteins mediates PRC2 complex targeting. Mol Cell. 2013;49(3):571-582.
-
(2013)
Mol Cell
, vol.49
, Issue.3
, pp. 571-582
-
-
Cai, L.1
Rothbart, S.B.2
Lu, R.3
-
10
-
-
84857367297
-
RYBPPRC1 complexes mediate H2A ubiquitylation at polycomb target sites independently of PRC2 and H3K27me3
-
Tavares L, Dimitrova E, Oxley D, et al. RYBPPRC1 complexes mediate H2A ubiquitylation at polycomb target sites independently of PRC2 and H3K27me3. Cell. 2012;148(4):664-678.
-
(2012)
Cell
, vol.148
, Issue.4
, pp. 664-678
-
-
Tavares, L.1
Dimitrova, E.2
Oxley, D.3
-
11
-
-
76149142791
-
Polycomb complexes act redundantly to repress genomic repeats and genes
-
Leeb M, Pasini D, Novatchkova M, Jaritz M, Helin K, Wutz A. Polycomb complexes act redundantly to repress genomic repeats and genes. Genes Dev. 2010;24(3):265-276.
-
(2010)
Genes Dev
, vol.24
, Issue.3
, pp. 265-276
-
-
Leeb, M.1
Pasini, D.2
Novatchkova, M.3
Jaritz, M.4
Helin, K.5
Wutz, A.6
-
12
-
-
84902333500
-
Targeting polycomb to pericentric heterochromatin in embryonic stem cells reveals a role for H2AK119u1 in PRC2 recruitment
-
Cooper S, Dienstbier M, Hassan R, et al. Targeting polycomb to pericentric heterochromatin in embryonic stem cells reveals a role for H2AK119u1 in PRC2 recruitment. Cell Reports. 2014;7(5):1456-1470.
-
(2014)
Cell Reports
, vol.7
, Issue.5
, pp. 1456-1470
-
-
Cooper, S.1
Dienstbier, M.2
Hassan, R.3
-
13
-
-
84902127230
-
Variant PRC1 complex-dependent H2A ubiquitylation drives PRC2 recruitment and polycomb domain formation
-
Blackledge NP, Farcas AM, Kondo T, et al. Variant PRC1 complex-dependent H2A ubiquitylation drives PRC2 recruitment and polycomb domain formation. Cell. 2014;157(6): 1445-1459.
-
(2014)
Cell
, vol.157
, Issue.6
, pp. 1445-1459
-
-
Blackledge, N.P.1
Farcas, A.M.2
Kondo, T.3
-
14
-
-
84901987800
-
Histone H2A monoubiquitination promotes histone H3 methylation in Polycomb repression
-
Kalb R, Latwiel S, Baymaz HI, et al. Histone H2A monoubiquitination promotes histone H3 methylation in Polycomb repression. Nat Struct Mol Biol. 2014;21(6):569-571.
-
(2014)
Nat Struct Mol Biol
, vol.21
, Issue.6
, pp. 569-571
-
-
Kalb, R.1
Latwiel, S.2
Baymaz, H.I.3
-
15
-
-
84893152923
-
The central role of EED in the orchestration of polycomb group complexes
-
Cao Q, Wang X, Zhao M, et al. The central role of EED in the orchestration of polycomb group complexes. Nat Commun. 2014;5:3127.
-
(2014)
Nat Commun
, vol.5
, pp. 3127
-
-
Cao, Q.1
Wang, X.2
Zhao, M.3
-
16
-
-
70350500219
-
Polycomb group proteins: Navigators of lineage pathways led astray in cancer
-
Bracken AP, Helin K. Polycomb group proteins: navigators of lineage pathways led astray in cancer. Nat Rev Cancer. 2009;9(11):773-784.
-
(2009)
Nat Rev Cancer
, vol.9
, Issue.11
, pp. 773-784
-
-
Bracken, A.P.1
Helin, K.2
-
17
-
-
33847084602
-
Genome regulation by polycomb and trithorax proteins
-
Schuettengruber B, Chourrout D, Vervoort M, Leblanc B, Cavalli G. Genome regulation by polycomb and trithorax proteins. Cell. 2007; 128(4):735-745.
-
(2007)
Cell
, vol.128
, Issue.4
, pp. 735-745
-
-
Schuettengruber, B.1
Chourrout, D.2
Vervoort, M.3
Leblanc, B.4
Cavalli, G.5
-
18
-
-
0025863346
-
Identification of cooperating oncogenes in e mu-myc transgenic mice by provirus tagging
-
van Lohuizen M, Verbeek S, Scheijen B, Wientjens E, van der Gulden H, Berns A. Identification of cooperating oncogenes in E mu-myc transgenic mice by provirus tagging. Cell. 1991;65(5):737-752.
-
(1991)
Cell
, vol.65
, Issue.5
, pp. 737-752
-
-
Van Lohuizen, M.1
Verbeek, S.2
Scheijen, B.3
Wientjens, E.4
Van Der Gulden, H.5
Berns, A.6
-
19
-
-
78650454078
-
Coordinated activities of wild-type plus mutant EZH2 drive tumor-associated hypertrimethylation of lysine 27 on histone H3 (H3K27) in human B-cell lymphomas
-
Sneeringer CJ, Scott MP, Kuntz KW, et al. Coordinated activities of wild-type plus mutant EZH2 drive tumor-associated hypertrimethylation of lysine 27 on histone H3 (H3K27) in human B-cell lymphomas. Proc Natl Acad Sci USA. 2010;107(49):20980-20985.
-
(2010)
Proc Natl Acad Sci USA
, vol.107
, Issue.49
, pp. 20980-20985
-
-
Sneeringer, C.J.1
Scott, M.P.2
Kuntz, K.W.3
-
20
-
-
79952167230
-
Somatic mutations at EZH2 Y641 act dominantly through a mechanism of selectively altered PRC2 catalytic activity, to increase H3K27 trimethylation
-
Yap DB, Chu J, Berg T, et al. Somatic mutations at EZH2 Y641 act dominantly through a mechanism of selectively altered PRC2 catalytic activity, to increase H3K27 trimethylation. Blood. 2011;117(8):2451-2459.
-
(2011)
Blood
, vol.117
, Issue.8
, pp. 2451-2459
-
-
Yap, D.B.1
Chu, J.2
Berg, T.3
-
21
-
-
37549015263
-
Germinal centres: Role in B-cell physiology and malignancy
-
Klein U, Dalla-Favera R. Germinal centres: role in B-cell physiology and malignancy. Nat Rev Immunol. 2008;8(1):22-33.
-
(2008)
Nat Rev Immunol
, vol.8
, Issue.1
, pp. 22-33
-
-
Klein, U.1
Dalla-Favera, R.2
-
22
-
-
34548544648
-
Chromatin remodeling and cancer Part II: ATP-dependent chromatin remodeling
-
Wang GG, Allis CD, Chi P. Chromatin remodeling and cancer, Part II: ATP-dependent chromatin remodeling. Trends Mol Med. 2007; 13(9):373-380.
-
(2007)
Trends Mol Med
, vol.13
, Issue.9
, pp. 373-380
-
-
Wang, G.G.1
Allis, C.D.2
Chi, P.3
-
23
-
-
84904051194
-
Role of microRNAs in B cell leukemias and lymphomas
-
Schmidt A, Küppers R. Role of microRNAs in B cell leukemias and lymphomas. Curr Mol Med. 2014;14(5):580-597.
-
(2014)
Curr Mol Med
, vol.14
, Issue.5
, pp. 580-597
-
-
Schmidt, A.1
Küppers, R.2
-
24
-
-
0033970457
-
Cutting edge: Polycomb gene expression patterns reflect distinct B cell differentiation stages in human germinal centers
-
Raaphorst FM, van Kemenade FJ, Fieret E, et al. Cutting edge: polycomb gene expression patterns reflect distinct B cell differentiation stages in human germinal centers. J Immunol. 2000;164(1):1-4.
-
(2000)
J Immunol
, vol.164
, Issue.1
, pp. 1-4
-
-
Raaphorst, F.M.1
Van Kemenade, F.J.2
Fieret, E.3
-
25
-
-
0035873747
-
Distinct BMI-1 and EZH2 expression patterns in thymocytes and mature T cells suggest a role for Polycomb genes in human T cell differentiation
-
Raaphorst FM, Otte AP, van Kemenade FJ, et al. Distinct BMI-1 and EZH2 expression patterns in thymocytes and mature T cells suggest a role for Polycomb genes in human T cell differentiation. J Immunol. 2001;166(10): 5925-5934.
-
(2001)
J Immunol
, vol.166
, Issue.10
, pp. 5925-5934
-
-
Raaphorst, F.M.1
Otte, A.P.2
Van Kemenade, F.J.3
-
26
-
-
3442876431
-
Distinct expression patterns of polycomb oncoproteins and their binding partners during the germinal center reaction
-
van Galen JC, Dukers DF, Giroth C, et al. Distinct expression patterns of polycomb oncoproteins and their binding partners during the germinal center reaction. Eur J Immunol. 2004;34(7):1870-1881.
-
(2004)
Eur J Immunol
, vol.34
, Issue.7
, pp. 1870-1881
-
-
Van Galen, J.C.1
Dukers, D.F.2
Giroth, C.3
-
27
-
-
0035877978
-
Coexpression of BMI-1 and EZH2 polycomb-group proteins is associated with cycling cells and degree of malignancy in B-cell non-Hodgkin lymphoma
-
van Kemenade FJ, Raaphorst FM, Blokzijl T, et al. Coexpression of BMI-1 and EZH2 polycomb-group proteins is associated with cycling cells and degree of malignancy in B-cell non-Hodgkin lymphoma. Blood. 2001;97(12): 3896-3901.
-
(2001)
Blood
, vol.97
, Issue.12
, pp. 3896-3901
-
-
Van Kemenade, F.J.1
Raaphorst, F.M.2
Blokzijl, T.3
-
28
-
-
0035050744
-
The Polycomb group protein EZH2 is upregulated in proliferating, cultured human mantle cell lymphoma
-
Visser HP, Gunster MJ, Kluin-Nelemans HC, et al. The Polycomb group protein EZH2 is upregulated in proliferating, cultured human mantle cell lymphoma. Br J Haematol. 2001; 112(4):950-958.
-
(2001)
Br J Haematol
, vol.112
, Issue.4
, pp. 950-958
-
-
Visser, H.P.1
Gunster, M.J.2
Kluin-Nelemans, H.C.3
-
29
-
-
77449159608
-
Poised lineage specification in multipotential hematopoietic stem and progenitor cells by the polycomb protein Bmi1
-
Oguro H, Yuan J, Ichikawa H, et al. Poised lineage specification in multipotential hematopoietic stem and progenitor cells by the polycomb protein Bmi1. Cell Stem Cell. 2010; 6(3):279-286.
-
(2010)
Cell Stem Cell
, vol.6
, Issue.3
, pp. 279-286
-
-
Oguro, H.1
Yuan, J.2
Ichikawa, H.3
-
30
-
-
0033569429
-
Bmi-1 collaborates with c-Myc in tumorigenesis by inhibiting c-Mycinduced apoptosis via INK4a/ARF
-
Jacobs JJ, Scheijen B, Voncken JW, Kieboom K, Berns A, van Lohuizen M. Bmi-1 collaborates with c-Myc in tumorigenesis by inhibiting c-Mycinduced apoptosis via INK4a/ARF. Genes Dev. 1999;13(20):2678-2690.
-
(1999)
Genes Dev
, vol.13
, Issue.20
, pp. 2678-2690
-
-
Jacobs, J.J.1
Scheijen, B.2
Voncken, J.W.3
Kieboom, K.4
Berns, A.5
Van Lohuizen, M.6
-
31
-
-
43549126021
-
Bmi1 regulates memory CD4 T cell survival via repression of the Noxa gene
-
Yamashita M, Kuwahara M, Suzuki A, et al. Bmi1 regulates memory CD4 T cell survival via repression of the Noxa gene. J Exp Med. 2008; 205(5):1109-1120.
-
(2008)
J Exp Med
, vol.205
, Issue.5
, pp. 1109-1120
-
-
Yamashita, M.1
Kuwahara, M.2
Suzuki, A.3
-
32
-
-
77954376911
-
The Polycomb group protein Bmi-1 is essential for the growth of multiple myeloma cells
-
Jagani Z, Wiederschain D, Loo A, et al. The Polycomb group protein Bmi-1 is essential for the growth of multiple myeloma cells. Cancer Res. 2010;70(13):5528-5538.
-
(2010)
Cancer Res
, vol.70
, Issue.13
, pp. 5528-5538
-
-
Jagani, Z.1
Wiederschain, D.2
Loo, A.3
-
33
-
-
84889080811
-
Aggressive variants of non-Hodgkin lymphomas, Ezh2 is strongly expressed and polycomb repressive complex PRC1.4 dominates over PRC1.2
-
Abd Al Kader L, Oka T, Takata K, et al. In aggressive variants of non-Hodgkin lymphomas, Ezh2 is strongly expressed and polycomb repressive complex PRC1.4 dominates over PRC1.2. Virchows Arch. 2013;463(5):697-711.
-
(2013)
Virchows Arch
, vol.463
, Issue.5
, pp. 697-711
-
-
Abd Al Kader, L.1
Oka, T.2
Takata, K.3
-
34
-
-
33846982558
-
Expression of the polycomb-group gene BMI1 is related to an unfavourable prognosis in primary nodal DLBCL
-
van Galen JC, Muris JJ, Oudejans JJ, et al. Expression of the polycomb-group gene BMI1 is related to an unfavourable prognosis in primary nodal DLBCL. J Clin Pathol. 2007;60(2): 167-172.
-
(2007)
J Clin Pathol
, vol.60
, Issue.2
, pp. 167-172
-
-
Van Galen, J.C.1
Muris, J.J.2
Oudejans, J.J.3
-
35
-
-
84883052280
-
BMI1, the polycomb-group gene, is recurrently targeted by genomic rearrangements in progressive B-cell leukemia/lymphoma
-
Rouhigharabaei L, Ferreiro JF, Put N, et al. BMI1, the polycomb-group gene, is recurrently targeted by genomic rearrangements in progressive B-cell leukemia/lymphoma. Genes Chromosomes Cancer. 2013;52(10):928-944.
-
(2013)
Genes Chromosomes Cancer
, vol.52
, Issue.10
, pp. 928-944
-
-
Rouhigharabaei, L.1
Ferreiro, J.F.2
Put, N.3
-
36
-
-
20444457518
-
Microarray analysis identifies a death-fromcancer signature predicting therapy failure in patients with multiple types of cancer
-
Glinsky GV, Berezovska O, Glinskii AB. Microarray analysis identifies a death-fromcancer signature predicting therapy failure in patients with multiple types of cancer. J Clin Invest. 2005;115(6):1503-1521.
-
(2005)
J Clin Invest
, vol.115
, Issue.6
, pp. 1503-1521
-
-
Glinsky, G.V.1
Berezovska, O.2
Glinskii, A.B.3
-
37
-
-
0037673984
-
Bmi-1 determines the proliferative capacity of normal and leukaemic stem cells
-
Lessard J, Sauvageau G. Bmi-1 determines the proliferative capacity of normal and leukaemic stem cells. Nature. 2003;423(6937):255-260.
-
(2003)
Nature
, vol.423
, Issue.6937
, pp. 255-260
-
-
Lessard, J.1
Sauvageau, G.2
-
38
-
-
0038349957
-
Bmi-1 is required for maintenance of adult self-renewing haematopoietic stem cells
-
Park IK, Qian D, Kiel M, et al. Bmi-1 is required for maintenance of adult self-renewing haematopoietic stem cells. Nature. 2003; 423(6937):302-305.
-
(2003)
Nature
, vol.423
, Issue.6937
, pp. 302-305
-
-
Park, I.K.1
Qian, D.2
Kiel, M.3
-
39
-
-
34248328001
-
Role of the chromobox protein CBX7 in lymphomagenesis
-
Scott CL, Gil J, Hernando E, et al. Role of the chromobox protein CBX7 in lymphomagenesis. Proc Natl Acad Sci USA. 2007;104(13): 5389-5394.
-
(2007)
Proc Natl Acad Sci USA
, vol.104
, Issue.13
, pp. 5389-5394
-
-
Scott, C.L.1
Gil, J.2
Hernando, E.3
-
40
-
-
78651431143
-
Variations in chromosomes 9 and 6p21.3 with risk of non-Hodgkin lymphoma
-
Wang SS, Menashe I, Cerhan JR, et al. Variations in chromosomes 9 and 6p21.3 with risk of non-Hodgkin lymphoma. Cancer Epidemiol Biomarkers Prev. 2011;20(1):42-49.
-
(2011)
Cancer Epidemiol Biomarkers Prev
, vol.20
, Issue.1
, pp. 42-49
-
-
Wang, S.S.1
Menashe, I.2
Cerhan, J.R.3
-
41
-
-
33646161725
-
Variability in the expression of polycomb proteins in different normal and tumoral tissues. A pilot study using tissue microarrays
-
Sánchez-Beato M, Sánchez E, González-Carreró J, et al. Variability in the expression of polycomb proteins in different normal and tumoral tissues. A pilot study using tissue microarrays. Mod Pathol. 2006;19(5):684-694.
-
(2006)
Mod Pathol
, vol.19
, Issue.5
, pp. 684-694
-
-
Sánchez-Beato, M.1
Sánchez, E.2
González-Carreró, J.3
-
42
-
-
38549106607
-
Inactivation of the polycomb group protein Ring1B unveils an antiproliferative role in hematopoietic cell expansion and cooperation with tumorigenesis associated with Ink4a deletion
-
Calés C, Román-Trufero M, Pavón L, et al. Inactivation of the polycomb group protein Ring1B unveils an antiproliferative role in hematopoietic cell expansion and cooperation with tumorigenesis associated with Ink4a deletion. Mol Cell Biol. 2008;28(3):1018-1028.
-
(2008)
Mol Cell Biol
, vol.28
, Issue.3
, pp. 1018-1028
-
-
Calés, C.1
Román-Trufero, M.2
Pavón, L.3
-
43
-
-
84866378702
-
The role of mutations in epigenetic regulators in myeloid malignancies
-
Shih AH, Abdel-Wahab O, Patel JP, Levine RL. The role of mutations in epigenetic regulators in myeloid malignancies. Nat Rev Cancer. 2012; 12(9):599-612.
-
(2012)
Nat Rev Cancer
, vol.12
, Issue.9
, pp. 599-612
-
-
Shih, A.H.1
Abdel-Wahab, O.2
Patel, J.P.3
Levine, R.L.4
-
44
-
-
84859295400
-
A key role for EZH2 and associated genes in mouse and human adult T-cell acute leukemia
-
Simon C, Chagraoui J, Krosl J, et al. A key role for EZH2 and associated genes in mouse and human adult T-cell acute leukemia. Genes Dev. 2012;26(7):651-656.
-
(2012)
Genes Dev
, vol.26
, Issue.7
, pp. 651-656
-
-
Simon, C.1
Chagraoui, J.2
Krosl, J.3
-
45
-
-
84856747744
-
Genetic inactivation of the polycomb repressive complex 2 in T cell acute lymphoblastic leukemia
-
Ntziachristos P, Tsirigos A, Van Vlierberghe P, et al. Genetic inactivation of the polycomb repressive complex 2 in T cell acute lymphoblastic leukemia. Nat Med. 2012;18(2): 298-301.
-
(2012)
Nat Med
, vol.18
, Issue.2
, pp. 298-301
-
-
Ntziachristos, P.1
Tsirigos, A.2
Van Vlierberghe, P.3
-
46
-
-
0037320925
-
Ezh2 controls B cell development through histone H3 methylation and Igh rearrangement
-
Su IH, Basavaraj A, Krutchinsky AN, et al. Ezh2 controls B cell development through histone H3 methylation and Igh rearrangement. Nat Immunol. 2003;4(2):124-131.
-
(2003)
Nat Immunol
, vol.4
, Issue.2
, pp. 124-131
-
-
Su, I.H.1
Basavaraj, A.2
Krutchinsky, A.N.3
-
47
-
-
84890046467
-
Germinal center dysregulation by histone methyltransferase EZH2 promotes lymphomagenesis
-
Caganova M, Carrisi C, Varano G, et al. Germinal center dysregulation by histone methyltransferase EZH2 promotes lymphomagenesis. J Clin Invest. 2013;123(12): 5009-5022.
-
(2013)
J Clin Invest
, vol.123
, Issue.12
, pp. 5009-5022
-
-
Caganova, M.1
Carrisi, C.2
Varano, G.3
-
48
-
-
77957256995
-
Deregulated expression of the polycomb-group protein SUZ12 target genes characterizes mantle cell lymphoma
-
Martín-Pérez D, Sánchez E, Maestre L, et al. Deregulated expression of the polycomb-group protein SUZ12 target genes characterizes mantle cell lymphoma. Am J Pathol. 2010; 177(2):930-942.
-
(2010)
Am J Pathol
, vol.177
, Issue.2
, pp. 930-942
-
-
Martín-Pérez, D.1
Sánchez, E.2
Maestre, L.3
-
49
-
-
84891603187
-
EZH2 mutations are frequent and represent an early event in follicular lymphoma
-
Bödör C, Grossmann V, Popov N, et al. EZH2 mutations are frequent and represent an early event in follicular lymphoma. Blood. 2013; 122(18):3165-3168.
-
(2013)
Blood
, vol.122
, Issue.18
, pp. 3165-3168
-
-
Bödör, C.1
Grossmann, V.2
Popov, N.3
-
50
-
-
84914177439
-
Reaction coupling between wild-type and disease-associated mutant EZH2
-
Swalm BM, Knutson SK, Warholic NM, et al. Reaction coupling between wild-type and disease-associated mutant EZH2. ACS Chem Biol. 2014;9(11):2459-2464.
-
(2014)
ACS Chem Biol
, vol.9
, Issue.11
, pp. 2459-2464
-
-
Swalm, B.M.1
Knutson, S.K.2
Warholic, N.M.3
-
51
-
-
34249026300
-
Highresolution profiling of histone methylations in the human genome
-
Barski A, Cuddapah S, Cui K, et al. Highresolution profiling of histone methylations in the human genome. Cell. 2007;129(4):823-837.
-
(2007)
Cell
, vol.129
, Issue.4
, pp. 823-837
-
-
Barski, A.1
Cuddapah, S.2
Cui, K.3
-
52
-
-
84866597616
-
A687V EZH2 is a gain-of-function mutation found in lymphoma patients
-
Majer CR, Jin L, Scott MP, et al. A687V EZH2 is a gain-of-function mutation found in lymphoma patients. FEBS Lett. 2012;586(19):3448-3451.
-
(2012)
FEBS Lett
, vol.586
, Issue.19
, pp. 3448-3451
-
-
Majer, C.R.1
Jin, L.2
Scott, M.P.3
-
53
-
-
84863165348
-
Mutation of A677 in histone methyltransferase EZH2 in human B-cell lymphoma promotes hypertrimethylation of histone H3 on lysine 27 (H3K27
-
McCabe MT, Graves AP, Ganji G, et al. Mutation of A677 in histone methyltransferase EZH2 in human B-cell lymphoma promotes hypertrimethylation of histone H3 on lysine 27 (H3K27). Proc Natl Acad Sci USA. 2012;109(8): 2989-2994.
-
(2012)
Proc Natl Acad Sci USA
, vol.109
, Issue.8
, pp. 2989-2994
-
-
McCabe, M.T.1
Graves, A.P.2
Ganji, G.3
-
54
-
-
84918547001
-
A687V EZH2 is a Driver of Histone H3 Lysine 27 (H3K27) Hypertrimethylation
-
Ott HM, Graves AP, Pappalardi MB, et al. A687V EZH2 Is a Driver of Histone H3 Lysine 27 (H3K27) Hypertrimethylation. Mol Cancer Ther. 2014;13(12):3062-3073.
-
(2014)
Mol Cancer Ther
, vol.13
, Issue.12
, pp. 3062-3073
-
-
Ott, H.M.1
Graves, A.P.2
Pappalardi, M.B.3
-
55
-
-
84923319561
-
Oncogenic Y641 mutations in EZH2 prevent Jak2/b-TrCP-mediated degradation [published online ahead of print January 27, 2014]
-
Sahasrabuddhe AA, Chen X, Chung F, Velusamy T, Lim MS, Elenitoba-Johnson KS. Oncogenic Y641 mutations in EZH2 prevent Jak2/b-TrCP-mediated degradation [published online ahead of print January 27, 2014]. Oncogene.
-
Oncogene
-
-
Sahasrabuddhe, A.A.1
Chen, X.2
Chung, F.3
Velusamy, T.4
Lim, M.S.5
Elenitoba-Johnson, K.S.6
-
56
-
-
84877815031
-
EZH2 is required for germinal center formation and somatic EZH2 mutations promote lymphoid transformation
-
Béguelin W, Popovic R, Teater M, et al. EZH2 is required for germinal center formation and somatic EZH2 mutations promote lymphoid transformation. Cancer Cell. 2013;23(5): 677-692.
-
(2013)
Cancer Cell
, vol.23
, Issue.5
, pp. 677-692
-
-
Béguelin, W.1
Popovic, R.2
Teater, M.3
-
57
-
-
78650062951
-
EZH2-mediated epigenetic silencing in germinal center B cells contributes to proliferation and lymphomagenesis
-
Velichutina I, Shaknovich R, Geng H, et al. EZH2-mediated epigenetic silencing in germinal center B cells contributes to proliferation and lymphomagenesis. Blood. 2010;116(24): 5247-5255.
-
(2010)
Blood
, vol.116
, Issue.24
, pp. 5247-5255
-
-
Velichutina, I.1
Shaknovich, R.2
Geng, H.3
-
58
-
-
84902665681
-
A transgenic mouse model demonstrating the oncogenic role of mutations in the polycomb-group gene EZH2 in lymphomagenesis
-
Berg T, Thoene S, Yap D, et al. A transgenic mouse model demonstrating the oncogenic role of mutations in the polycomb-group gene EZH2 in lymphomagenesis. Blood. 2014;123(25): 3914-3924.
-
(2014)
Blood
, vol.123
, Issue.25
, pp. 3914-3924
-
-
Berg, T.1
Thoene, S.2
Yap, D.3
-
59
-
-
84891524411
-
Polycomb repressive complex 2 (PRC2) suppresses Emmyc lymphoma
-
Lee SC, Phipson B, Hyland CD, et al. Polycomb repressive complex 2 (PRC2) suppresses Emmyc lymphoma. Blood. 2013;122(15): 2654-2663.
-
(2013)
Blood
, vol.122
, Issue.15
, pp. 2654-2663
-
-
Lee, S.C.1
Phipson, B.2
Hyland, C.D.3
-
60
-
-
0032751323
-
Transcriptional repression mediated by the human polycombgroup protein EED involves histone deacetylation
-
van der Vlag J, Otte AP. Transcriptional repression mediated by the human polycombgroup protein EED involves histone deacetylation. Nat Genet. 1999;23(4):474-478.
-
(1999)
Nat Genet
, vol.23
, Issue.4
, pp. 474-478
-
-
Van Der Vlag, J.1
Otte, A.P.2
-
61
-
-
70350494322
-
Combined epigenetic therapy with the histone methyltransferase EZH2 inhibitor 3-deazaneplanocin A and the histone deacetylase inhibitor panobinostat against human AML cells
-
Fiskus W, Wang Y, Sreekumar A, et al. Combined epigenetic therapy with the histone methyltransferase EZH2 inhibitor 3-deazaneplanocin A and the histone deacetylase inhibitor panobinostat against human AML cells. Blood. 2009;114(13):2733-2743.
-
(2009)
Blood
, vol.114
, Issue.13
, pp. 2733-2743
-
-
Fiskus, W.1
Wang, Y.2
Sreekumar, A.3
-
62
-
-
33846569960
-
A stem celllike chromatin pattern may predispose tumor suppressor genes to DNA hypermethylation and heritable silencing
-
Ohm JE, McGarvey KM, Yu X, et al. A stem celllike chromatin pattern may predispose tumor suppressor genes to DNA hypermethylation and heritable silencing. Nat Genet. 2007;39(2): 237-242.
-
(2007)
Nat Genet
, vol.39
, Issue.2
, pp. 237-242
-
-
Ohm, J.E.1
McGarvey, K.M.2
Yu, X.3
-
63
-
-
33846649587
-
Polycomb-mediated methylation on Lys27 of histone H3 pre-marks genes for de novo methylation in cancer
-
Schlesinger Y, Straussman R, Keshet I, et al. Polycomb-mediated methylation on Lys27 of histone H3 pre-marks genes for de novo methylation in cancer. Nat Genet. 2007;39(2): 232-236.
-
(2007)
Nat Genet
, vol.39
, Issue.2
, pp. 232-236
-
-
Schlesinger, Y.1
Straussman, R.2
Keshet, I.3
-
64
-
-
32844459336
-
The Polycomb group protein EZH2 directly controls DNA methylation
-
Vir é E, Brenner C, Deplus R, et al. The Polycomb group protein EZH2 directly controls DNA methylation. Nature. 2006;439(7078): 871-874.
-
(2006)
Nature
, vol.439
, Issue.7078
, pp. 871-874
-
-
Viré, E.1
Brenner, C.2
Deplus, R.3
-
65
-
-
64049094683
-
New insights into the biology and origin of mature aggressive B-cell lymphomas by combined epigenomic, genomic, and transcriptional profiling
-
Martín-Subero JI, Kreuz M, Bibikova M, et al; Molecular Mechanisms in Malignant Lymphomas Network Project of the Deutsche Krebshilfe. New insights into the biology and origin of mature aggressive B-cell lymphomas by combined epigenomic, genomic, and transcriptional profiling. Blood. 2009;113(11):2488-2497.
-
(2009)
Blood
, vol.113
, Issue.11
, pp. 2488-2497
-
-
Martín-Subero, J.I.1
Kreuz, M.2
Bibikova, M.3
-
66
-
-
79952381408
-
CREBBP mutations in relapsed acute lymphoblastic leukaemia
-
Mullighan CG, Zhang J, Kasper LH, et al. CREBBP mutations in relapsed acute lymphoblastic leukaemia. Nature. 2011; 471(7337):235-239.
-
(2011)
Nature
, vol.471
, Issue.7337
, pp. 235-239
-
-
Mullighan, C.G.1
Zhang, J.2
Kasper, L.H.3
-
67
-
-
61349112251
-
MYC stimulates EZH2 expression by repression of its negative regulator miR-26a
-
Sander S, Bullinger L, Klapproth K, et al. MYC stimulates EZH2 expression by repression of its negative regulator miR-26a. Blood. 2008; 112(10):4202-4212.
-
(2008)
Blood
, vol.112
, Issue.10
, pp. 4202-4212
-
-
Sander, S.1
Bullinger, L.2
Klapproth, K.3
-
68
-
-
58149239686
-
Genomic loss of microRNA-101 leads to overexpression of histone methyltransferase EZH2 in cancer
-
Varambally S, Cao Q, Mani RS, et al. Genomic loss of microRNA-101 leads to overexpression of histone methyltransferase EZH2 in cancer. Science. 2008;322(5908):1695-1699.
-
(2008)
Science
, vol.322
, Issue.5908
, pp. 1695-1699
-
-
Varambally, S.1
Cao, Q.2
Mani, R.S.3
-
69
-
-
80051590718
-
Coordinated regulation of polycomb group complexes through microRNAs in cancer
-
Cao Q, Mani RS, Ateeq B, et al. Coordinated regulation of polycomb group complexes through microRNAs in cancer. Cancer Cell. 2011;20(2): 187-199.
-
(2011)
Cancer Cell
, vol.20
, Issue.2
, pp. 187-199
-
-
Cao, Q.1
Mani, R.S.2
Ateeq, B.3
-
70
-
-
68049114782
-
Downregulation of miRNA-200c links breast cancer stem cells with normal stem cells
-
Shimono Y, Zabala M, Cho RW, et al. Downregulation of miRNA-200c links breast cancer stem cells with normal stem cells. Cell. 2009;138(3):592-603.
-
(2009)
Cell
, vol.138
, Issue.3
, pp. 592-603
-
-
Shimono, Y.1
Zabala, M.2
Cho, R.W.3
-
71
-
-
73049110243
-
The EMT-activator ZEB1 promotes tumorigenicity by repressing stemness-inhibiting microRNAs
-
Wellner U, Schubert J, Burk UC, et al. The EMT-activator ZEB1 promotes tumorigenicity by repressing stemness-inhibiting microRNAs. Nat Cell Biol. 2009;11(12):1487-1495.
-
(2009)
Nat Cell Biol
, vol.11
, Issue.12
, pp. 1487-1495
-
-
Wellner, U.1
Schubert, J.2
Burk, U.C.3
-
72
-
-
48449084118
-
Connecting microRNA genes to the core transcriptional regulatory circuitry of embryonic stem cells
-
Marson A, Levine SS, Cole MF, et al. Connecting microRNA genes to the core transcriptional regulatory circuitry of embryonic stem cells. Cell. 2008;134(3):521-533.
-
(2008)
Cell
, vol.134
, Issue.3
, pp. 521-533
-
-
Marson, A.1
Levine, S.S.2
Cole, M.F.3
-
73
-
-
84862907856
-
Polycomb-mediated loss of miR-31 activates NIK-dependent NF-kB pathway in adult T cell leukemia and other cancers
-
Yamagishi M, Nakano K, Miyake A, et al. Polycomb-mediated loss of miR-31 activates NIK-dependent NF-kB pathway in adult T cell leukemia and other cancers. Cancer Cell. 2012; 21(1):121-135.
-
(2012)
Cancer Cell
, vol.21
, Issue.1
, pp. 121-135
-
-
Yamagishi, M.1
Nakano, K.2
Miyake, A.3
-
74
-
-
84907421890
-
Down regulation of miR200c promotes radiation-induced thymic lymphoma by targeting BMI1
-
Cui J, Cheng Y, Zhang P, et al. Down regulation of miR200c promotes radiation-induced thymic lymphoma by targeting BMI1. J Cell Biochem. 2014;115(6):1033-1042.
-
(2014)
J Cell Biochem
, vol.115
, Issue.6
, pp. 1033-1042
-
-
Cui, J.1
Cheng, Y.2
Zhang, P.3
-
75
-
-
84867606040
-
Coordinated silencing of MYC-mediated miR-29 by HDAC3 and EZH2 as a therapeutic target of histone modification in aggressive B-Cell lymphomas
-
Zhang X, Zhao X, Fiskus W, et al. Coordinated silencing of MYC-mediated miR-29 by HDAC3 and EZH2 as a therapeutic target of histone modification in aggressive B-Cell lymphomas. Cancer Cell. 2012;22(4):506-523.
-
(2012)
Cancer Cell
, vol.22
, Issue.4
, pp. 506-523
-
-
Zhang, X.1
Zhao, X.2
Fiskus, W.3
-
76
-
-
84862315462
-
Myc represses miR-15a/miR-16-1 expression through recruitment of HDAC3 in mantle cell and other non-Hodgkin B-cell lymphomas
-
Zhang X, Chen X, Lin J, et al. Myc represses miR-15a/miR-16-1 expression through recruitment of HDAC3 in mantle cell and other non-Hodgkin B-cell lymphomas. Oncogene. 2012;31(24):3002-3008.
-
(2012)
Oncogene
, vol.31
, Issue.24
, pp. 3002-3008
-
-
Zhang, X.1
Chen, X.2
Lin, J.3
-
77
-
-
84890430327
-
Disruption of the MYC-miRNA-EZH2 loop to suppress aggressive B-cell lymphoma survival and clonogenicity
-
Zhao X, Lwin T, Zhang X, et al. Disruption of the MYC-miRNA-EZH2 loop to suppress aggressive B-cell lymphoma survival and clonogenicity. Leukemia. 2013;27(12):2341-2350.
-
(2013)
Leukemia
, vol.27
, Issue.12
, pp. 2341-2350
-
-
Zhao, X.1
Lwin, T.2
Zhang, X.3
-
78
-
-
84892615509
-
C-MYC-miRNA circuitry: A central regulator of aggressive B-cell malignancies
-
Tao J, Zhao X, Tao J. c-MYC-miRNA circuitry: a central regulator of aggressive B-cell malignancies. Cell Cycle. 2014;13(2):191-198.
-
(2014)
Cell Cycle
, vol.13
, Issue.2
, pp. 191-198
-
-
Tao, J.1
Zhao, X.2
Tao, J.3
-
79
-
-
37549008310
-
Widespread microRNA repression by Myc contributes to tumorigenesis
-
Chang TC, Yu D, Lee YS, et al. Widespread microRNA repression by Myc contributes to tumorigenesis. Nat Genet. 2008;40(1):43-50.
-
(2008)
Nat Genet
, vol.40
, Issue.1
, pp. 43-50
-
-
Chang, T.C.1
Yu, D.2
Lee, Y.S.3
-
80
-
-
84899475386
-
C-Myc-mediated epigenetic silencing of MicroRNA-101 contributes to dysregulation of multiple pathways in hepatocellular carcinoma
-
Wang L, Zhang X, Jia LT, et al. c-Myc-mediated epigenetic silencing of MicroRNA-101 contributes to dysregulation of multiple pathways in hepatocellular carcinoma. Hepatology. 2014; 59(5):1850-1863.
-
(2014)
Hepatology
, vol.59
, Issue.5
, pp. 1850-1863
-
-
Wang, L.1
Zhang, X.2
Jia, L.T.3
-
81
-
-
25444520537
-
MiR-15 and miR-16 induce apoptosis by targeting BCL2
-
Cimmino A, Calin GA, Fabbri M, et al. miR-15 and miR-16 induce apoptosis by targeting BCL2. Proc Natl Acad Sci USA. 2005;102(39): 13944-13949.
-
(2005)
Proc Natl Acad Sci USA
, vol.102
, Issue.39
, pp. 13944-13949
-
-
Cimmino, A.1
Calin, G.A.2
Fabbri, M.3
-
82
-
-
77951003346
-
MicroRNA expression profile and identification of miR-29 as a prognostic marker and pathogenetic factor by targeting CDK6 in mantle cell lymphoma
-
Zhao JJ, Lin J, Lwin T, et al. microRNA expression profile and identification of miR-29 as a prognostic marker and pathogenetic factor by targeting CDK6 in mantle cell lymphoma. Blood. 2010;115(13):2630-2639.
-
(2010)
Blood
, vol.115
, Issue.13
, pp. 2630-2639
-
-
Zhao, J.J.1
Lin, J.2
Lwin, T.3
-
83
-
-
77955435090
-
Chronic lymphocytic leukemia modeled in mouse by targeted miR-29 expression
-
Santanam U, Zanesi N, Efanov A, et al. Chronic lymphocytic leukemia modeled in mouse by targeted miR-29 expression. Proc Natl Acad Sci USA. 2010;107(27):12210-12215.
-
(2010)
Proc Natl Acad Sci USA
, vol.107
, Issue.27
, pp. 12210-12215
-
-
Santanam, U.1
Zanesi, N.2
Efanov, A.3
-
84
-
-
84887421655
-
A microenvironment-mediated c-Myc/miR-548m/ HDAC6 amplification loop in non-Hodgkin B cell lymphomas
-
Lwin T, Zhao X, Cheng F, et al. A microenvironment-mediated c-Myc/miR-548m/ HDAC6 amplification loop in non-Hodgkin B cell lymphomas. J Clin Invest. 2013;123(11): 4612-4626.
-
(2013)
J Clin Invest
, vol.123
, Issue.11
, pp. 4612-4626
-
-
Lwin, T.1
Zhao, X.2
Cheng, F.3
-
85
-
-
84902344652
-
Histone deacetylase inhibitor prevents cell growth in Burkitt's lymphoma by regulating PI3K/Akt pathways and leads to upregulation of miR-143, miR-145, and miR-101
-
Ferreira AC, Robaina MC, Rezende LM, Severino P, Klumb CE. Histone deacetylase inhibitor prevents cell growth in Burkitt's lymphoma by regulating PI3K/Akt pathways and leads to upregulation of miR-143, miR-145, and miR-101. Ann Hematol. 2014;93(6):983-993.
-
(2014)
Ann Hematol
, vol.93
, Issue.6
, pp. 983-993
-
-
Ferreira, A.C.1
Robaina, M.C.2
Rezende, L.M.3
Severino, P.4
Klumb, C.E.5
-
86
-
-
84891852738
-
Selfrenewal as a therapeutic target in human colorectal cancer
-
Kreso A, van Galen P, Pedley NM, et al. Selfrenewal as a therapeutic target in human colorectal cancer. Nat Med. 2014;20(1):29-36.
-
(2014)
Nat Med
, vol.20
, Issue.1
, pp. 29-36
-
-
Kreso, A.1
Van Galen, P.2
Pedley, N.M.3
-
87
-
-
84870573126
-
EZH2 inhibition as a therapeutic strategy for lymphoma with EZH2-activating mutations
-
McCabe MT, Ott HM, Ganji G, et al. EZH2 inhibition as a therapeutic strategy for lymphoma with EZH2-activating mutations. Nature. 2012; 492(7427):108-112.
-
(2012)
Nature
, vol.492
, Issue.7427
, pp. 108-112
-
-
McCabe, M.T.1
Ott, H.M.2
Ganji, G.3
-
88
-
-
84867632489
-
A selective inhibitor of EZH2 blocks H3K27 methylation and kills mutant lymphoma cells
-
Knutson SK, Wigle TJ, Warholic NM, et al. A selective inhibitor of EZH2 blocks H3K27 methylation and kills mutant lymphoma cells. Nat Chem Biol. 2012;8(11):890-896.
-
(2012)
Nat Chem Biol
, vol.8
, Issue.11
, pp. 890-896
-
-
Knutson, S.K.1
Wigle, T.J.2
Warholic, N.M.3
-
89
-
-
84871841675
-
Selective inhibition of Ezh2 by a small molecule inhibitor blocks tumor cells proliferation
-
Qi W, Chan H, Teng L, et al. Selective inhibition of Ezh2 by a small molecule inhibitor blocks tumor cells proliferation. Proc Natl Acad Sci USA. 2012;109(52):21360-21365.
-
(2012)
Proc Natl Acad Sci USA
, vol.109
, Issue.52
, pp. 21360-21365
-
-
Qi, W.1
Chan, H.2
Teng, L.3
-
90
-
-
84879750981
-
An orally bioavailable chemical probe of the Lysine Methyltransferases EZH2 and EZH1
-
Konze KD, Ma A, Li F, et al. An orally bioavailable chemical probe of the Lysine Methyltransferases EZH2 and EZH1. ACS Chem Biol. 2013;8(6):1324-1334.
-
(2013)
ACS Chem Biol
, vol.8
, Issue.6
, pp. 1324-1334
-
-
Konze, K.D.1
Ma, A.2
Li, F.3
-
91
-
-
84877324084
-
Durable tumor regression in genetically altered malignant rhabdoid tumors by inhibition of methyltransferase EZH2
-
Knutson SK, Warholic NM, Wigle TJ, et al. Durable tumor regression in genetically altered malignant rhabdoid tumors by inhibition of methyltransferase EZH2. Proc Natl Acad Sci USA. 2013;110(19): 7922-7927.
-
(2013)
Proc Natl Acad Sci USA
, vol.110
, Issue.19
, pp. 7922-7927
-
-
Knutson, S.K.1
Warholic, N.M.2
Wigle, T.J.3
-
92
-
-
84888303259
-
Identification of EZH2 and EZH1 small molecule inhibitors with selective impact on diffuse large B cell lymphoma cell growth
-
Garapaty-Rao S, Nasveschuk C, Gagnon A, et al. Identification of EZH2 and EZH1 small molecule inhibitors with selective impact on diffuse large B cell lymphoma cell growth. Chem Biol. 2013;20(11):1329-1339.
-
(2013)
Chem Biol
, vol.20
, Issue.11
, pp. 1329-1339
-
-
Garapaty-Rao, S.1
Nasveschuk, C.2
Gagnon, A.3
-
93
-
-
84911462255
-
EZH2 inhibitor efficacy in non-hodgkin's lymphoma does not require suppression of h3k27 monomethylation
-
Bradley WD, Arora S, Busby J, et al. EZH2 Inhibitor Efficacy in Non-Hodgkin's Lymphoma Does Not Require Suppression of H3K27 Monomethylation. Chem Biol. 2014;21(11): 1463-1475.
-
(2014)
Chem Biol
, vol.21
, Issue.11
, pp. 1463-1475
-
-
Bradley, W.D.1
Arora, S.2
Busby, J.3
-
94
-
-
84921318899
-
Selective inhibition of EZH2 by EPZ-6438 leads to potent antitumor activity in EZH2-mutant non-Hodgkin lymphoma
-
Knutson SK, Kawano S, Minoshima Y, et al. Selective inhibition of EZH2 by EPZ-6438 leads to potent antitumor activity in EZH2-mutant non-Hodgkin lymphoma. Mol Cancer Ther. 2014;13(4):842-854.
-
(2014)
Mol Cancer Ther
, vol.13
, Issue.4
, pp. 842-854
-
-
Knutson, S.K.1
Kawano, S.2
Minoshima, Y.3
-
95
-
-
84921000037
-
Selective inhibition of EZH2 and EZH1 enzymatic activity by a small molecule suppresses MLL-rearranged leukemia [published online ahead of print November 13, 2014]
-
Xu B, On DM, Ma A, et al. Selective inhibition of EZH2 and EZH1 enzymatic activity by a small molecule suppresses MLL-rearranged leukemia [published online ahead of print November 13, 2014]. Blood. 2015;125(2): 346-357.
-
(2015)
Blood
, vol.125
, Issue.2
, pp. 346-357
-
-
Xu, B.1
On, D.M.2
Ma, A.3
-
96
-
-
79960058024
-
Selective killing of mixed lineage leukemia cells by a potent small-molecule DOT1L inhibitor
-
Daigle SR, Olhava EJ, Therkelsen CA, et al. Selective killing of mixed lineage leukemia cells by a potent small-molecule DOT1L inhibitor. Cancer Cell. 2011;20(1):53-65.
-
(2011)
Cancer Cell
, vol.20
, Issue.1
, pp. 53-65
-
-
Daigle, S.R.1
Olhava, E.J.2
Therkelsen, C.A.3
-
97
-
-
84879000598
-
Phosphorylation of EZH2 activates STAT3 signaling via STAT3 methylation and promotes tumorigenicity of glioblastoma stem-like cells
-
Kim E, Kim M, Woo DH, et al. Phosphorylation of EZH2 activates STAT3 signaling via STAT3 methylation and promotes tumorigenicity of glioblastoma stem-like cells. Cancer Cell. 2013; 23(6):839-852.
-
(2013)
Cancer Cell
, vol.23
, Issue.6
, pp. 839-852
-
-
Kim, E.1
Kim, M.2
Woo, D.H.3
-
98
-
-
84871052080
-
EZH2 oncogenic activity in castration-resistant prostate cancer cells is Polycomb-independent
-
Xu K, Wu ZJ, Groner AC, et al. EZH2 oncogenic activity in castration-resistant prostate cancer cells is Polycomb-independent. Science. 2012; 338(6113):1465-1469.
-
(2012)
Science
, vol.338
, Issue.6113
, pp. 1465-1469
-
-
Xu, K.1
Wu, Z.J.2
Groner, A.C.3
-
99
-
-
84907572364
-
Histone methyltransferase MMSET/ NSD2 alters EZH2 binding and reprograms the myeloma epigenome through global and focal changes in H3K36 and H3K27 methylation
-
Popovic R, Martinez-Garcia E, Giannopoulou EG, et al. Histone methyltransferase MMSET/ NSD2 alters EZH2 binding and reprograms the myeloma epigenome through global and focal changes in H3K36 and H3K27 methylation. PLoS Genet. 2014;10(9): e1004566.
-
(2014)
PLoS Genet
, vol.10
, Issue.9
, pp. e1004566
-
-
Popovic, R.1
Martinez-Garcia, E.2
Giannopoulou, E.G.3
-
100
-
-
84859475727
-
Polycomb repressive complex 2 is required for MLL-AF9 leukemia
-
Neff T, Sinha AU, Kluk MJ, et al. Polycomb repressive complex 2 is required for MLL-AF9 leukemia. Proc Natl Acad Sci USA. 2012; 109(13):5028-5033.
-
(2012)
Proc Natl Acad Sci USA
, vol.109
, Issue.13
, pp. 5028-5033
-
-
Neff, T.1
Sinha, A.U.2
Kluk, M.J.3
|